{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:07:27Z","timestamp":1763417247133,"version":"3.45.0"},"reference-count":3,"publisher":"American College of Physicians","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.7326\/annals-25-04088-jc","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:00:40Z","timestamp":1762207240000},"page":"JC127","source":"Crossref","is-referenced-by-count":0,"title":["In cancer-associated thrombosis, DOACs reduce VTE and increase clinically relevant nonmajor bleeding vs. LMWH at 3 to 12 mo"],"prefix":"10.7326","volume":"178","author":[{"given":"Alejandro","family":"Godoy","sequence":"first","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada (A.G., J.D.D.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Douketis","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada (A.G., J.D.D.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ACP Journal Club Editorial Team at McMaster University","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","reference":[{"key":"ANNALS-25-04088-R1","unstructured":"Lee AY, Levine MN, Baker RI, et al; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators.\n                      Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153. [PMID: 12853587]"},{"key":"ANNALS-25-04088-R2","doi-asserted-by":"crossref","unstructured":"Lyman GH, Carrier M, Ay C, et al.\n                      American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5:927-974. [PMID: 33570602]","DOI":"10.1182\/bloodadvances.2021004734"},{"key":"ANNALS-25-04088-R3","doi-asserted-by":"crossref","unstructured":"Falanga A, Ay C, Di Nisio M, et al; ESMO Guidelines Committee.\n                      Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol. 2023;34:452-467. [PMID: 36638869]","DOI":"10.1016\/j.annonc.2022.12.014"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-25-04088-JC","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-25-04088-JC","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:01:41Z","timestamp":1763416901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-25-04088-JC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":3,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.7326\/ANNALS-25-04088-JC"],"URL":"https:\/\/doi.org\/10.7326\/annals-25-04088-jc","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"type":"print","value":"0003-4819"},{"type":"electronic","value":"1539-3704"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}